Clinical Trial NCT03520647
Trial
NHLBI – 180090 18-h-0090 (NCT03520647)
Clinical trial ID
NCT03520647
Drug name
Cyclophosphamide
Company:
NHLBI
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
2
Current status
Recruiting
Start
02/2019
Substance
Cytostatic
Research question
Haplo-identical transplantation and post-transplant cyclophosphamide in sAA and PNH
Delivery method of drug
i.v.
Frequency
Once, hospital stay over weeks
Clinical trial locations
USA